Tomoki Imaoka
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 13
- Drug Transport and Resistance Mechanisms 10
- HER2/EGFR in Cancer Research 2
-
- Pharmacological Effects and Toxicity Studies 5
- Co-authors
- Hiroyuki Kusuhara (5 shared papers)Yuichi Sugiyama (4 shared papers)Masashi Adachi (1 shared paper)Kenji Takeuchi (1 shared paper)John D. Schuetz (1 shared paper)Hitoshi Endou (3 shared papers)Hermann Koepsell (1 shared paper)Eiichi Fuse (1 shared paper)
- Journals
- Drug Metabolism and Disposition (3 papers)ACS Medicinal Chemistry Letters (2 papers)Scientific Reports (2 papers)Journal of Pharmaceutical Sciences (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Tomoki Imaoka
20 papers receiving 702 citations
Peers
Comparison fields: 5 of 80
- Pharmacology 133
- Oncology 385
- Pediatrics, Perinatology and Child Health 248
- Virology 54
- Infectious Diseases 139
Countries citing papers authored by Tomoki Imaoka
This map shows the geographic impact of Tomoki Imaoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoki Imaoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoki Imaoka more than expected).
Fields of papers citing papers by Tomoki Imaoka
This network shows the impact of papers produced by Tomoki Imaoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoki Imaoka. The network helps show where Tomoki Imaoka may publish in the future.
Co-authors
The 25 scholars most cited alongside Tomoki Imaoka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 221 | |
| 2 | 2005 | 137 | |
| 3 | 2014 | 78 | |
| 4 | 2004 | 47 | |
| 5 | 2020 | 26 | |
| 6 | 2014 | 25 | |
| 7 | 2020 | 23 | |
| 8 | 2021 | 21 | |
| 9 | 1993 | 21 | |
| 10 | 2018 | 21 | |
| 11 | 2019 | 19 | |
| 12 | 2021 | 18 | |
| 13 | 2013 | 18 | |
| 14 | 2004 | 15 | |
| 15 | 2015 | 9 | |
| 16 | 2024 | 6 | |
| 17 | 2023 | 5 | |
| 18 | [Metabolic characteristics and antitumor activity of BOF-A2, a new 5-fluorouracil derivative]. | 1990 | 5 |
| 19 | 2019 | 2 | |
| 20 | 2024 | 1 |
About Tomoki Imaoka
Tomoki Imaoka is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Molecular Biology, Nephrology and Pharmaceutical Science, having authored 20 papers that have together received 718 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (10 papers), Pharmacological Effects and Toxicity Studies (5 papers), Ion Transport and Channel Regulation (3 papers), Drug Solubulity and Delivery Systems (2 papers), Pancreatic function and diabetes (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), HER2/EGFR in Cancer Research (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Pharmacology (133 citations), Oncology (385 citations), Pediatrics, Perinatology and Child Health (248 citations), Virology (54 citations) and Infectious Diseases (139 citations). Tomoki Imaoka has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Hiroyuki Kusuhara, Yuichi Sugiyama, Masashi Adachi, Kenji Takeuchi, John D. Schuetz, Hitoshi Endou, Hermann Koepsell, Eiichi Fuse, Harunobu Tahara and Takashi Izumi. Their work appears in journals such as Drug Metabolism and Disposition, ACS Medicinal Chemistry Letters, Scientific Reports, Journal of Pharmaceutical Sciences and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.